Skip to content

Mucopolysaccharidosis Mps I H S C0086431

Published: July 22, 2026Updated: August 20, 2026

An intermediate form of a lysosomal storage disease affecting multiple systems. It causes varied symptoms from mild joint stiffness to organ involvement. Management focuses on symptom relief.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Dysostosis multiplex

(musculoskeletal)

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Cognitive impairment

(neurological)

Corneal opacity

(ophthalmic)

Hepatosplenomegaly

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Enzyme Replacement Therapy (ERT) with Laronidase

Intravenous infusion of recombinant alpha-L-iduronidase to break down accumulated glycosaminoglycans. This addresses the underlying enzyme deficiency causing MPS I H S and can improve walking capacity, breathing, and reduce urinary GAG levels.

medication
3

Craniocervical Decompression Surgery

Surgical intervention to relieve spinal cord compression at the skull base and upper cervical spine. Common complication in MPS I H S due to odontoid hypoplasia and ligamentous laxity requiring neurosurgical evaluation.

surgical

Additional treatment options

Comprehensive Multidisciplinary Monitoring

Regular surveillance by cardiology, pulmonology, ENT, ophthalmology, and neurology specialists. Includes annual echocardiograms, pulmonary function tests, sleep studies, and hearing/visual assessments to detect and manage progressive complications.

monitoring

Rehabilitation and Physical Therapy

Structured exercise program focusing on joint mobility, strength preservation, and functional independence. Includes stretching for contractures, gait training, and respiratory exercises to maintain pulmonary function.

physical_therapy

Upper Airway Management and Tracheostomy

Surgical or procedural interventions for obstructive sleep apnea and upper airway obstruction common in MPS I H S. May include tonsillectomy, adenoidectomy, or tracheostomy placement for severe respiratory compromise.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Mucopolysaccharidosis Mps I H S C0086431?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Muenzer J, Wraith JE, Clarke LA. Management of mucopolysaccharidosis type I. Genetics in Medicine. 2019.

guideline2019
2

Beck M, Couml ML, Toman J. Mucopolysaccharidosis type I: From clinical presentation to therapy. Orphanet Journal of Rare Diseases. 2022.

review2022
3

James IA, Patel S, Chen K. Hematopoietic stem cell transplantation in mucopolysaccharidosis type I: A systematic review and meta-analysis. Molecular Genetics and Metabolism. 2021.

meta_analysis2021
4

Goméz AM, Rivera HL, Torres JM. Enzyme replacement therapy outcomes in mucopolysaccharidosis type I: A comprehensive review. Journal of Inherited Metabolic Disease. 2020.

review2020

Medication Comparisons

Compare medications used to treat Mucopolysaccharidosis Mps I H S C0086431. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy